RetinalGenix Technologies (RTGN) Net Cash Flow (QoQ) (2021 - 2026)
RetinalGenix Technologies (RTGN) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -199.40% |
| Dec 31, 2025 | 2,065.46% |
| Sep 30, 2025 | 73.99% |
| Jun 30, 2025 | -22.26% |
| Mar 31, 2025 | 96.78% |
| Dec 31, 2024 | -833.40% |
| Sep 30, 2024 | -121.42% |
| Jun 30, 2024 | -27.51% |
| Mar 31, 2024 | 114,613.64% |
| Dec 31, 2023 | 97.65% |
| Sep 30, 2023 | 66.37% |
| Jun 30, 2023 | -174.77% |
| Mar 31, 2023 | 307.95% |
| Dec 31, 2022 | -191.83% |
| Sep 30, 2022 | 253.96% |
| Jun 30, 2022 | -5.69% |
| Mar 31, 2022 | 92.44% |
| Dec 31, 2021 | -189.56% |
| Sep 30, 2021 | 20,316.18% |
| Jun 30, 2021 | 115.26% |